Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - Other
Ratios

Bristol Myers Squibb (BMYMP) Leases (2019 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Leases for 7 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • Quarterly Leases rose 29.25% to $1.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, up 29.25% year-over-year, with the annual reading at $1.6 billion for FY2025, 29.25% up from the prior year.
  • Leases for Q4 2025 was $1.6 billion at Bristol Myers Squibb, down from $1.6 billion in the prior quarter.
  • The five-year high for Leases was $1.6 billion in Q3 2025, with the low at $840.0 million in Q2 2022.
  • Average Leases over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2023.
  • The sharpest move saw Leases dropped 16.5% in 2022, then skyrocketed 54.81% in 2023.
  • Over 5 years, Leases stood at $919.0 million in 2021, then skyrocketed by 32.75% to $1.2 billion in 2022, then increased by 13.93% to $1.4 billion in 2023, then dropped by 11.94% to $1.2 billion in 2024, then rose by 29.25% to $1.6 billion in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $1.6 billion, $1.6 billion, and $1.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.